Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effectiveness of bupropion combined with behavioral therapy for methamphetamine dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bupropion (bupropion)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Methamphetamine | Phase 2 | Status: COMPLETED